ESMO Clinical Trial Results and US Market Decline
META Meta Platforms Inc
$610.15 +0.84%
View chart & analysis → - 1Clinical trials presented at the ESMO conference show improvements in actual survival rates beyond tumor size reduction.
- 2US stock market values fell for two consecutive weeks due to AI spending concerns and rising oil prices.
- 3Brent crude prices hit $116.72 on Friday, reaching a six-month high amid Middle East concerns.
So what's the key point?
Results from the ESMO conference showed that cancer treatments improved survival rates. The US stock market fell for two weeks due to concerns over AI costs and rising oil prices.
Source The Motley Fool · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.